AIDS Drug Assistance Program Report Offers Sobering View of Programs
June 14, 2002
AIDS Drug Assistance Programs (ADAPs) are facing growth problems that have resulted in restricted access to drugs and capped enrollment in at least 10 US states and territories, according to the April 2002 annual ADAP report of the National ADAP Monitoring Project, prepared by the Henry J. Kaiser Family Foundation.Adapted from:
As of February 2002, Alabama, Georgia, Idaho, Kentucky, Maine, North Carolina, South Dakota, Texas, Wyoming and Guam had restrictions. Maine, Texas and Guam reported capped or restricted access to antiretroviral drugs; others had expenditure caps and capped enrollment.
ADAP in Texas anticipates deficits of $7 million in 2002, $12 million in 2004 and $16 million in 2002. Problems for states like Texas surfaced even as the national ADAP budget grew by 12 percent, to $810 million in fiscal year 2001 -- a fourfold increase since FY 1996. State ADAP funding also increased by an average of 12 percent to $149.6 million in FY 2001, although 16 states provided no state funding and relied solely on federal funds. The report makes it clear that even double-digit funding increases are not keeping pace with the need.
Ten states serve 77 percent of all ADAP clients, according to June 2001 data, and the top five serve 61 percent of all clients. Among other key findings:
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.